PACTR201906616852062
Recruiting
N/A
A comprehensive intervention for cardiovascular disease prevention in selected primary health care facilities in Capricorn District, South Africa: An effectiveness-implementation study
niversity of Limpopo0 sites600 target enrollmentApril 25, 2019
ConditionsCardiology
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Cardiology
- Sponsor
- niversity of Limpopo
- Enrollment
- 600
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Both male and female
- •2\. Aged 18 years and above
- •3\. Consent to participate in the study
Exclusion Criteria
- •1\. Below age of 18
- •2\. Those not consenting to participate
- •3\. Those not falling withing the catchment areas of the identified 11 clinics in Capricorn District, Limpopo Province, South Africa.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, Not Recruiting
Phase 1
ew treatments to reduce cardiovascular disease in type 1 diabetesCTIS2023-505794-32-04Steno Diabetes Center Copenhagen2,000
Active, Not Recruiting
N/A
MiFoot – reducing heart disease risk in those with a history of diabetic foot ulcersDiabetesNutritional, Metabolic, EndocrineISRCTN13413505niversity of Leicester392
Active, Not Recruiting
N/A
Comparison between 2 different hydration strategies (saline solution vs carbonati) for the prevention of contrast induced nephropaty in patients at risk for heart failure undergoing coronary angiography or interventioPatients undergoing coronary angiography or angioplastyMedDRA version: 14.1Level: SOCClassification code 10007541Term: Cardiac disordersSystem Organ Class: 10007541 - Cardiac disordersTherapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2011-003611-37-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA' DI NOVARA240
Active, Not Recruiting
N/A
PRevEntion of cardiac and Vascular pEriprocedural complications in patients undergoiNg coronary angiography or angioplasTy: IntraCoronary Adenosine administration to prevent peRiprocedUral myonecrosiS in elective coronary angioplasty. A prospective double-blind randomized trial (PREVENT ICARUS) trial - PREVENT-ICARUSElective coronary angioplastyMedDRA version: 9.1Level: SOCClassification code 10047065EUCTR2009-013681-92-ITAZIENDA OSPEDALIERA MAGGIORE DELLA CARITA` DI NOVARA
Active, Not Recruiting
Phase 1
Treatment of heart and blood vessel disease (cardiovascular disease) with low dose blood thinner (low dose rivaroxaban) in people with advanced kidney disease or receiving dialysis (advanced chronic kidney disease).Improvement of cardiovascular outcomes in patients with advancedchronic kidney disease. In easily understood language, this is Heart and blood vessel disease and Kidney disease.Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]CTIS2024-512483-59-00The George Institute For Global Health2,000